🇺🇸 FDA
Patent

US 11324734

Compositions and methods for treating anemia

granted A61KA61K31/16A61K31/4418

Quick answer

US patent 11324734 (Compositions and methods for treating anemia) held by Akebia Therapeutics, Inc. expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Akebia Therapeutics, Inc.
Grant date
Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/16, A61K31/4418, A61K9/2009, A61K9/2013